Berberine promotes primordial follicle activation and increases ovulated oocyte quantity in aged mice

• Published in: Molecular medicine (Cambridge, Mass.) Mass.), 2024-12, Vol.30 (1), p.251-13, Article 251
• Main Authors: Liu, Shuang, Wang, Weiyong, Liu, Huiyu, Wei, Hongwei, Weng, Yashuang, Zhou, Wenjun, Zhang, Xiaodan, He, Sihui, Chen, Ye, Wang, Yahong, Zhang, Meijia, Chen, Xin
• Format: Article
• Language: English
• Subjects: Aging; Akt; Animals; Berberine; Berberine - pharmacology; Female; Humans; Mice; Oocytes - drug effects; Oocytes - metabolism; Ovarian Follicle - drug effects; Ovarian Follicle - metabolism; Phosphatidylinositol 3-Kinases - metabolism; Premature ovarian insufficiency; Primordial follicle activation; Proto-Oncogene Proteins c-akt - metabolism; Signal Transduction - drug effects
• ISSN: 1528-3658; 1528-3658
• DOI: 10.1186/s10020-024-01042-z

Primordial follicle activation is vital for the reproduction of women with advanced age and premature ovarian insufficiency (POI). But there is a lack of effective and safe therapeutic options to activate their primordial follicles in vivo. Berberine (BBR) possesses multiple pharmacological properties, but its impact on primordial follicle activation remains unclear. The role of BBR on primordial activation was investigated by neonatal mouse ovary culture and intraperitoneal injection, and by human ovarian fragment culture. Furthermore, the effect of BBR on the quantity of ovulated oocytes was investigated by the intragastric administration of aged mice. BBR in vitro culture and in vivo intraperitoneal injection significantly increased growing follicle number and phosphorylated protein kinase B (p-Akt) levels in neonatal mouse ovaries. BBR also significantly increased the relative fluorescence intensities of p-Akt in the oocytes of primordial follicles. BBR-increased the number of growing follicles and the levels of p-Akt were blocked by LY294002, an inhibitor of phosphatidylinositol 3-kinase (PI3K). Furthermore, BBR intragastric administration significantly increased the quantity of ovulated oocytes in aged mice. Moreover, BBR significantly increased growing follicle proportion and p-Akt levels in cultured human ovarian fragments. BBR promotes mouse and human primordial follicle activation through the PI3K/Akt pathway in oocytes, and improves the quantity of ovulated oocytes in aged mice. Our results suggest a potential use of oral medicine BBR to improve fertility in POI patients and aged women.